These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15941616)

  • 21. Outcome of clinical pregnancies after ovulation induction using metformin.
    Turner MJ; Walsh J; Byrne KM; Murphy C; Langan H; Farah N
    J Obstet Gynaecol; 2006 Apr; 26(3):233-5. PubMed ID: 16698631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
    Sharma ST; Nestler JE
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
    Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L; de Zegher F
    Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients.
    Palomba S; Falbo A; Orio F; Zullo F
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):364-73. PubMed ID: 18660688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
    Palomba S; Falbo A; Russo T; Orio F; Tollino A; Zullo F
    Minerva Ginecol; 2008 Feb; 60(1):77-82. PubMed ID: 18277354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS
    Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome.
    Hadžiomerović-Pekić D; Wildt L; Weiss JM; Moeller K; Mattle V; Seeber BE
    Fertil Steril; 2010 Nov; 94(6):2385-8. PubMed ID: 20356587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.
    Neveu N; Granger L; St-Michel P; Lavoie HB
    Fertil Steril; 2007 Jan; 87(1):113-20. PubMed ID: 17081535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
    Ibáñez L; de Zegher F
    Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin and polycystic ovary syndrome.
    Lebinger TG
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):132-40. PubMed ID: 17940431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
    Cheang KI; Sharma ST; Nestler JE
    Gynecol Endocrinol; 2006 Nov; 22(11):595-604. PubMed ID: 17145645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study.
    Qublan HS; Yannakoula EK; Al-Qudah MA; El-Uri FI
    Saudi Med J; 2007 Nov; 28(11):1694-9. PubMed ID: 17965792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovary syndrome in adolescents.
    Kent SC; Legro RS
    Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.